Hong Kong stocks surge | Quanshi Biology-B (02509.HK) surges more than 13% again in the first half of the year, with significant growth in performance. Recently received heavy investment from TruMed Fund.

According to the Securities Times app, Qilu Biotechnology-B (02509.HK) has risen by over 13% again, with a cumulative increase of nearly 300% since the beginning of the year. As of the time of writing, it has risen by 9.26% to 27.6 Hong Kong dollars, with a trading volume of 45.4043 million Hong Kong dollars.